Publications Search

Search for publications by author
Search for publications by abstract keyword(s)

Search results

5092 items matching your search terms.
An analysis of a multiple biomarker panel to better predict prostate cancer metastasis after radical prostatectomy
Zhang, A. Y.; Chiam, K.; Haupt, Y.; Fox, S.; Birch, S.; Tilley, W.; Butler, L. M.; Knudsen, K.; Comstock, C.; Rasiah, K.; Grogan, J.; Mahon, K. L.; Bianco-Miotto, T.; Ricciardelli, C.; Bohm, M.; Henshall, S.; Delprado, W.; Stricker, P.; Horvath, L. G.; Kench, J. G.
INTERNATIONAL JOURNAL OF CANCER 144 (5) :1151-1159, 2019 10.1002/ijc.31906
MicroRNA-196a is regulated by ER and is a prognostic biomarker in ER+ breast cancer
Milevskiy, M. J. G.; Gujral, U.; Del Lama Marques, C.; Stone, A.; Northwood, K.; Burke, L. J.; Gee, J. M. W.; Nephew, K.; Clark, S.; Brown, M. A.
British Journal of Cancer 120 (6) :621-632, 2019 10.1038/s41416-019-0395-8
Overexpression of UHRF1 promoted the proliferation of vascular smooth cells via the regulation of Geminin protein levels
Chen, X.; Zhou, Y. L.; Liang, S. Y.; Shi, Y. C.; Lin, S.; Shu, M. Q.
BIOSCIENCE REPORTS 39 (2) 2019 10.1042/BSR20181341
Can we IMPROVE cardiovascular outcomes through phosphate lowering in CKD? Rationale and protocol for the IMpact of Phosphate Reduction On Vascular End-points in Chronic Kidney Disease (IMPROVE-CKD) study
Lioufas, N.; Toussaint, N. D.; Pedagogos, E.; Elder, G.; Badve, S. V.; Pascoe, E.; Valks, A.; Hawley, C.; Committee, Improve-Ckd Writing
BMJ Open 9 (2) :e024382, 2019 10.1136/bmjopen-2018-024382
Metagenomic and metatranscriptomic analysis of human prostate microbiota from patients with prostate cancer
Feng, Y.; Ramnarine, V. R.; Bell, R.; Volik, S.; Davicioni, E.; Hayes, V. M.; Ren, S.; Collins, C. C.
BMC Genomics 20 (1) :146, 2019 10.1186/s12864-019-5457-z
Microsimulation model for the health economic evaluation of osteoporosis interventions: study protocol
Si, L.; Eisman, J. A.; Winzenberg, T.; Sanders, K. M.; Center, J. R.; Nguyen, T. V.; Palmer, A. J.
BMJ Open 9 (2) :e028365, 2019 10.1136/bmjopen-2018-028365
Evaluation of cross-platform and interlaboratory concordance via consensus modelling of genomic measurements
Peters, T. J.; French, H. J.; Bradford, S. T.; Pidsley, R.; Stirzaker, C.; Varinli, H.; Nair, S.; Qu, W.; Song, J.; Giles, K. A.; Statham, A. L.; Speirs, H.; Speed, T. P.; Clark, S. J.
Bioinformatics 35 (4) :560-570, 2019 10.1093/bioinformatics/bty675
Integrated epigenomic analysis stratifies chromatin remodellers into distinct functional groups
Giles, K. A.; Gould, C. M.; Du, Q.; Skvortsova, K.; Song, J. Z.; Maddugoda, M. P.; Achinger-Kawecka, J.; Stirzaker, C.; Clark, S. J.; Taberlay, P. C.
Epigenetics & Chromatin 12 (1) :12, 2019 10.1186/s13072-019-0258-9
DNA Hypermethylation Encroachment at CpG Island Borders in Cancer Is Predisposed by H3K4 Monomethylation Patterns
Skvortsova, K.; Masle-Farquhar, E.; Luu, P. L.; Song, J. Z.; Qu, W.; Zotenko, E.; Gould, C. M.; Du, Q.; Peters, T. J.; Colino-Sanguino, Y.; Pidsley, R.; Nair, S. S.; Khoury, A.; Smith, G. C.; Miosge, L. A.; Reed, J. H.; Kench, J. G.; Rubin, M. A.; Horvath, L.; Bogdanovic, O.; Lim, S. M.; Polo, J. M.; Goodnow, C. C.; Stirzaker, C.; Clark, S. J.
CANCER CELL 35 (2) :297-314 e8, 2019 10.1016/j.ccell.2019.01.004
Optimise not compromise: The importance of a multidisciplinary breast cancer patient pathway in the era of oncoplastic and reconstructive surgery
Strach, M. C.; Prasanna, T.; Kirova, Y. M.; Alran, S.; O'Toole, S.; Beith, J. M.; Poortmans, P.; McNeil, C. M.; Carroll, S.
CRITICAL REVIEWS IN ONCOLOGY HEMATOLOGY 134 :10-21, 2019 10.1016/j.critrevonc.2018.11.007
Phenotypic and molecular dissection of Metaplastic Breast Cancer and the prognostic implications
McCart Reed, A. E.; Kalaw, E.; Nones, K.; Bettington, M.; Lim, M.; Bennett, J.; Johnstone, K.; Kutasovic, J. R.; Saunus, J. M.; Kazakoff, S.; Xu, Q.; Wood, S.; Holmes, O.; Leonard, C.; Reid, L. E.; Black, D.; Niland, C.; Ferguson, K.; Gresshoff, I.; Raghavendra, A.; Harvey, K.; Cooper, C.; Liu, C.; Kalinowski, L.; Reid, A. S.; Davidson, M.; Pearson, J. V.; Pathmanathan, N.; Tse, G.; Papadimos, D.; Pathmanathan, R.; Harris, G.; Yamaguchi, R.; Tan, P. H.; Fox, S.; O'Toole, S. A.; Simpson, P. T.; Waddell, N.; Lakhani, S. R.
JOURNAL OF PATHOLOGY 247 (2) :214-227, 2019 10.1002/path.5184
The Medical Genome Reference Bank: a whole-genome data resource of 4000 healthy elderly individuals. Rationale and cohort design
Lacaze, P.; Pinese, M.; Kaplan, W.; Stone, A.; Brion, M. J.; Woods, R. L.; McNamara, M.; McNeil, J. J.; Dinger, M. E.; Thomas, D. M.
EUROPEAN JOURNAL OF HUMAN GENETICS 27 (2) :308-316, 2019 10.1038/s41431-018-0279-z
Results of a prospective phase 2 pilot trial of (177)Lu-PSMA-617 therapy for metastatic castration-resistant prostate cancer including imaging predictors of treatment response and patterns of progression
Emmett, L.; Crumbaker, M.; Ho, B.; Willowson, K.; Eu, P.; Ratnayake, L.; Epstein, R.; Blanksby, A.; Horvath, L.; Guminski, A.; Mahon, K.; Gedye, C.; Yin, C.; Stricker, P.; Joshua, A. M.
Clinical Genitourinary Cancer 17 (1) :15-22, 2019 10.1016/j.clgc.2018.09.014
The impact of ethnicity on efficacy and toxicity of cyclin D kinase 4/6 inhibitors in advanced breast cancer: a meta-analysis
Lee, K. W. C.; Lord, S.; Finn, R. S.; Lim, E.; Martin, A.; Loi, S.; Lynch, J.; Friedlander, M.; Lee, C. K.
BREAST CANCER RESEARCH AND TREATMENT 174 (1) :271-278, 2019 10.1007/s10549-018-5054-x
Non-canonical AR activity facilitates endocrine resistance in breast cancer
Chia, K.; Milioli, H.; Portman, N.; Laven-Law, G.; Coulson, R.; Yong, A.; Segara, D.; Parker, A.; Caldon, C. E.; Deng, N.; Swarbrick, A.; Tilley, W. D.; Hickey, T. E.; Lim, E.
ENDOCRINE-RELATED CANCER 26 (2) :251-264, 2019 10.1530/erc-18-0333